Skip to main content

Charles River Laboratories Organic revenue (change on a year)

  • CRL · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$337.97−0.83%Close 13 Nov 2026 · Market value $16.04B

Organic revenue (change on a year) at Charles River Laboratories came to 5.9% for the quarter to 26 Sep 2026, down 0.6 points from a year earlier.

As Charles River Laboratories reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

−0.4%Dec 20233.3%Mar 2024−3.9%Jun 20240.6%Sep 2024−0.4%Dec 2024−2.5%Mar 20252.3%Jun 20256.5%Sep 2025−0.9%Dec 2025−5.5%Mar 2026−1.4%Jun 20265.9%Sep 2026
Charles River Laboratories Organic revenue (change on a year), every reported period
Period endingOrganic revenue (change on a year)Change on a yearFiled
26 Sep 20265.9%down 0.6 points4 Nov 2026
27 Jun 2026−1.4%down 3.7 points5 Aug 2026
28 Mar 2026−5.5%down 3.0 points7 May 2026
27 Dec 2025−0.9%down 0.5 points13 Jan 2026
27 Sep 20256.5%up 5.9 points5 Nov 2025
28 Jun 20252.3%up 6.2 points6 Aug 2025
29 Mar 2025−2.5%down 5.8 points7 May 2025
28 Dec 2024−0.4%unchanged19 Feb 2025
28 Sep 20240.6%—6 Nov 2024
29 Jun 2024−3.9%—7 Aug 2024
30 Mar 20243.3%—9 May 2024
30 Dec 2023−0.4%—14 Feb 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Shown as the change on the same period a year earlier, as the company prints it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Charles River Laboratories: Revenue · Remaining performance obligations · Cost of services provided (excluding amortization of intangible assets) revenue · Cost of products sold (excluding amortization of intangible assets) revenue · DSA revenue · RMS revenue · Manufacturing revenue · United States revenue · Europe revenue · Canada revenue · Asia Pacific revenue · financial statements

Every KPI and segment of CRL, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.